Nonexudative age-related macular degeneration, also known as dry AMD, is a common eye disorder affecting people aged 50 and above. It is caused by the deterioration of the macula, the central part of the retina responsible for sharp, detailed vision. The condition is characterized by the formation of small yellow deposits called drusen, which accumulate under the retina, causing it to thin and dry out.
Advanced atrophic with subfoveal involvement is a subtype of dry AMD that affects the macula's center, known as the fovea. The fovea is responsible for high-resolution vision, and its damage can lead to a significant loss of visual acuity. In this subtype, the atrophy extends to the area located below the fovea, known as the subfoveal region. This type of AMD is associated with a greater risk of vision loss.
Nonexudative age-related macular degeneration with subfoveal involvement can cause a range of symptoms, including:
It is important to note that the symptoms of AMD can vary from person to person and can worsen over time.
Several risk factors can increase the likelihood of developing nonexudative age-related macular degeneration with subfoveal involvement. These include:
While some risk factors, such as age and family history, cannot be changed, others, such as smoking and obesity, can be managed to reduce the risk of developing AMD.
Nonexudative age-related macular degeneration with subfoveal involvement is a common eye disorder that can cause significant visual impairment. While there is no cure for AMD, early detection and management can help slow the progression of the disease and preserve vision. If you
To see full information about treatment please Sign up or Log in